Perspective Therapeutics Total Liabilities

Perspective Therapeutics (ISR) currently reports a total liabilities of $68M as of June 2026. That compares with $45M in the prior-year period — up 51.4% year over year. Use the charts on this page to explore Perspective Therapeutics's total liabilities history and peer comparisons.

Perspective Therapeutics's total liabilities increased from $45M to $68M — a 51.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Perspective Therapeutics reported $68M in total liabilities as of June 2026. That compares with $45M in the prior-year period — up 51.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $68M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Perspective Therapeutics, and consider following ISR for alerts when major investors trade the stock.

Perspective Therapeutics is classified in the Industrials sector. On total liabilities, it currently shows $68M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing ISR with unrelated industries.